Pacira BioSciences, Inc.

PCRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $54.1M $35.9M $57.0M $37.5M $12.5M $12.5M $46.2M $26.1M
Accounts Receivable $31.7M $29.9M $25.9M $22.4M $14.6M $4.4M $2.1M $1.2M
Inventory $41.4M $31.3M $61.6M $29.3M $15.6M $12.1M $1.2M $1.6M
Total Current Assets $391.1M $243.1M $252.6M $214.3M $106.8M $60.9M $82.6M $31.1M
Property, Plant & Equipment $107.0M $101.0M $90.3M $60.6M $48.2M $39.1M $25.1M $24.0M
Goodwill $55.2M $46.7M $30.9M $23.8M $10.3M $8.3M $0 —
Intangible Assets (Excl. Goodwill) — $0 $81.0K $403.0K $1.2M $3.2M $5.3M $8.9M
Total Assets $628.4M $391.5M $387.7M $326.1M $169.8M $112.1M $113.5M $66.6M
Liabilities
Accounts Payable $14.7M $7.5M $8.7M $6.8M $3.1M $2.6M $3.4M $4.3M
Total Current Liabilities $56.2M $44.8M $149.8M $140.0M $121.9M $14.2M $31.9M $16.3M
Long-Term Debt — $108.7M $104.0M $103.1M $0 $25.2M $18.5M $21.9M
Total Liabilities $348.9M $172.5M $169.3M $154.9M $128.6M $46.2M $65.2M $114.9M
Stockholders' Equity
Retained Earnings $-389.1M $-346.2M $-308.3M $-310.1M $-296.4M $-232.5M $-180.2M $-136.9M
Total Stockholders' Equity $279.5M $219.0M $218.4M $171.1M $41.2M $65.9M $48.3M $-48.4M
← Newer Page 2 of 2 Older →